Monarch Specialty Group, a partnership firm and investment company focused on orphan drugs and specialty biologics, has added Howard Schwartz, MD, as a practice associate.
Dr. Schwartz, a board-certified gastroenterologist, has experience with more than 1,000 clinical trials in various specialties.
"Dr. Schwartz brings to the company a unique combination of medical practice and relevant commercial experience relating to specialty biologics that will add depth of knowledge to what is already a best-in-class contract commercial operations team," said Stephen Cichy, founder and managing director of Monarch.